CARDIOCOMM SOLUTIONS INC (EKG.CA) Stock Income Statement
TSX-V:EKG - TSX Venture Exchange - CA14159N2086 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 509.60K | 526.70K | 876.40K | 995.80K | 682.50K | |||
| Cost Of Goods | 31.20K | 26.10K | 139.00K | 268.40K | 71.70K | |||
| Gross Profit | 478.40K | 500.60K | 737.40K | 727.50K | 610.90K | |||
| Operating Expenses | 762.40K | 791.70K | 944.90K | 804.80K | 822.70K | |||
| Research and Development | N/A | N/A | N/A | 0.00 | 11.10K | |||
| Selling, General, and Administrative Expenses | 788.80K | 762.70K | 920.50K | 776.10K | 782.90K | |||
| Operating Income | -283.70K | -291.10K | -207.50K | -77.40K | -211.90K | |||
| Interest Income/Expense | -41.40K | -38.50K | -64.30K | -29.30K | -35.30K | |||
| Other Income/Expense | 67.10K | 135.10K | 174.50K | 104.20K | 266.20K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -18.70K | |||
| Income Before Taxes | -258.20K | -194.60K | -97.30K | -2.50K | 300.00 | |||
| Net Income | -258.20K | -194.60K | -97.30K | -2.50K | 300.00 | |||
| EBITDA | -254.60K | -262.10K | -183.10K | -48.70K | -183.30K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 93.88% | 95.04% | 84.14% | 73.06% | 89.51% | |||
| Profit Margin | -50.67% | -36.95% | -11.10% | -0.25% | 0.04% | |||
| Operating Profit Margin | -55.67% | -55.27% | -23.68% | -7.77% | -31.05% | |||
All data in CAD